Intestinal current measurement (ICM) as a new diagnostic test for cystic fibrosis (CF) Source: Annual Congress 2011 - Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation Year: 2011
Potential utility of the N2 VC SBW test in cystic fibrosis (CF) Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring Year: 2017
Nasal potential difference (NPD) in cystic fibrosis (CF) and non-CF patients with borderline sweat test Source: Eur Respir J 2001; 18: Suppl. 33, 215s Year: 2001
Nasal potential difference measurements in patients with atypical cystic fibrosis Source: Eur Respir J 2001; 17: 1208-1215 Year: 2001
Relationship between nasal potential difference (NPD) and respiratory function in cystic fibrosis (CF) patients Source: Eur Respir J 2001; 18: Suppl. 33, 125s Year: 2001
Atypical cystic fibrosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=38 Year: 2006
Intestinal current measurement (ICM) as a diagnostic tool for atypical cystic fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 340s Year: 2002
The impact of genotype on clinical course of cystic fibrosis (CF) in adult patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013
Diagnostic and therapeutic difficulties in pulmonary aspergillosis (PA) in paediatric cystic fibrosis (CF) patients Source: Eur Respir J 2006; 28: Suppl. 50, 485s Year: 2006
The oral AntibioticS approprIateness score (OASIS) – A novel scoring system to assess antibiotic route in pulmonary exacerbations of cystic fibrosis (CF) Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013
Evolution of the infectious disease in cystic fibrosis (CF) Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases Year: 2008
How useful is the lung ultrasound in cystic fibrosis? Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016
The diagnosis of cystic fibrosis by sweat test: the establishment of age specific reference intervals Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007
The need for lung transplantation in cystic fibrosis (CF) in the era of new treatment Source: Virtual Congress 2020 – Lung transplantation in the era of new drugs Year: 2020
Hyperinflation in adult cystic fibrosis (CF) patients: Clinical and functional correlates Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies Year: 2010
Analysis of relationship between Nasal Potential Difference, genotype and clinical phenotype in patients with cystic fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 341s Year: 2002
A borderline, or negative sweat test, leads to a diagnostic delay in hypertrypsinaemic cystic fibrosis (CF) infants with mild CFTR mutations Source: Eur Respir J 2001; 18: Suppl. 33, 124s Year: 2001
Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID) Source: Breathe, 17 (3) 210088; 10.1183/20734735.0088-2021 Year: 2021
Assessment of the work of breathing (sWOB) within different functional and genetic groups in patients with cystic fibrosis (CF) Source: Annual Congress 2013 –New perspectives of lung function assessment in children Year: 2013
Volumetric capnography: a promising lung function test in cystic fibrosis? Source: Virtual Congress 2020 – Respiratory physiology and sleep: from neonates to adults Year: 2020